Dividend11 Aug 2026, 04:42 pm
Tatva Chintan Pharma Chem Ltd Recommends Final Dividend of ₹2.00
AI Summary
Tatva Chintan Pharma Chem Ltd announced that its Board of Directors recommended a final dividend of ₹2.00 per equity share (20%) for the financial year ended March 31, 2026. This dividend is subject to shareholder approval at the upcoming 30th Annual General Meeting. The company also provided details regarding Tax Deduction at Source (TDS) for both resident and non-resident shareholders, outlining applicable rates and conditions for tax exemption or lower withholding tax, including the requirement for specific forms and declarations.
Key Highlights
- Board recommends final dividend of ₹2.00 per share for FY 2025-26.
- Dividend subject to shareholder approval at the 30th AGM.
- TDS rates and exemption procedures for resident shareholders detailed.
- Withholding tax rates for non-resident shareholders specified.
- Shareholders need to submit necessary documentation for tax benefits.
Price Impact
More from TATVA